Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian
123
Next »

Facility Trends: Modularization and Single Use

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.
May 1, 2013
By: Jennifer Markarian

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.

FDA Investigates Med Prep Consulting for Contaminated Intravenous Solution

Mar 21, 2013
By: Jennifer Markarian

The New Jersey-licensed specialty pharmacy recalls magnesium sulfate products and halts all production operations.

Daiichi Sankyo Condemns Falsely-represented Product

Mar 8, 2013
By: Jennifer Markarian

Product sold online in Malaysia and Indonesia infringes on the company’s trademark.

Report Explores Future of Opioid Abuse-Resistant Formulations

Feb 21, 2013
By: Jennifer Markarian

A GBI Research report says the opioid market will be driven by development of new products and post-marketing studies designed to reduce abuse risk.

GSK Announces Fourth Quarter 2012 Results and 2013 Plans

Feb 7, 2013
By: Jennifer Markarian

Group sales were down, but R&D progress points to future growth.

US Pharmacopeial Convention Announces Revised Official Dates for Elemental Impurities Chapters

Jan 31, 2013
By: Jennifer Markarian

Two general chapters on elemental impurities? limits and procedures are to become official Feb. 1, 2013, with implementation proposed for May 1, 2014.

Rutgers University Research Center and Janssen Develop Continuous Manufacturing Process

Jan 17, 2013
By: Jennifer Markarian

Rutgers engineers constructed a direct compaction line in collaboration with Janssen.

Eli Lilly Announces 2013 Financial Guidance

Jan 8, 2013
By: Jennifer Markarian

Eli Lilly expects overall revenue growth in the coming year.

US Supreme Court to Hear Pay-for-Delay Case

Dec 11, 2012
By: Jennifer Markarian

The US Supreme Court accepted an appeal by the Federal Trade Commission of a decision that upheld an arrangement of payments by Solvay Pharmaceuticals to generic drug companies to postpone introduction of generic versions of its branded testosterone-replacement drug.

123
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here